Logo KMS TEAM
Precise execution

MC Services is...

Client News

 

 

… an international Corporate Communications and Investor Relations firm providing high-level consultancy with targeted services and support for transaction-oriented assignments throughout Europe and the United States.

 

read more

 

MC Services one of the main sponsors of the 9th DVFA Life Science Conference 2016


MC Services will once again be one of the main sponsors of the 9th DVFA Life Science Conference, which takes place in Frankfurt on June 14, 2016. Over recent years the DVFA Life Science Conference has become a highly valued platform to discuss new innovative technologies, therapies and products with financial market participants.

This year’s conference titled "Next Level Targeted Therapies – Game Changing Technologies for Future Medicine" focuses on innovative treatment strategies and new therapies that have the potential to significantly change the treatment environment. Such a shift in cancer treatment includes immuno-oncology therapies, directing the immune system to eliminate tumor cells, libraries of highly specific and efficient antibodies against a broad portfolio of targets and personalized T-cell immunotherapies that are just some of the key developments in this field. MC Services’ clients have taken leading roles in the development of innovative approaches and exploring new ways of fighting cancer with the potential to transform current treatment approaches.

 

read more

 

MC Services sponsors Best Technology Award at the 2016 European Mediscience Awards


MC Services proudly contributed to this year’s European Mediscience Awards as sponsor of the Best Technology Award, for innovative technology that is well funded and capable of significant commercial success.

 

Mediscience Awards 2016: The winners have been crowned


It is done: after much anticipation the winners of the 2016 Mediscience Awards have been crowned! A huge congratulation to all the winners & shortlisted companies!


read more

 

Please also follow us on Twitter (@MCServicesAG)

Newron to Evaluate Burden of Disease for Rett Syndrome Patients and Families

www.newron.com

Nicox added to Russell Global Index

www.nicox.com

RedHill Biopharma Announces First Patients Dosed in Phase II Study with BEKINDA(TM) for IBS-D

www.redhillbio.com

VAXIMM Elects New Members to Board of Directors

www.vaximm.com

Two Recent Publications on Pritelivir Confirm the Potency of the Novel AiCuris Anti-Herpes Simplex Virus Drug

www.aicuris.com

U.S. FDA grants Priority Review for Nicox’s AC-170 New Drug Application

www.nicox.com

Kiadis Pharma Appoints PCT as its Contract Manufacturing Organization in the United States

www.kiadis.com

TxCell exercises option from Weizmann Institute of Science following effective grant of broad CAR-Treg patent in Europe

www.txcell.com

SYGNIS AG announces outcome of Annual General Meeting 2016 

www.sygnis.com

PAION reports positive remimazolam headline data in pivotal U.S. Phase III study in procedural sedation for colonoscopy

www.paion.com

Proposed Placing to raise c. £44.7 million (US$63.3 million) and Notice of General Meeting

www.veronapharma.com

TxCell implements a new financing contract of up to €20 million in nominal value through convertible notes with warrants (OCABSA)

www.txcell.com